Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

471 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Adjuvant immunotherapy in patients with resected gastric and oesophagogastric junction cancer following preoperative chemotherapy with high risk for recurrence (ypN+ and/or R1): European Organisation of Research and Treatment of Cancer (EORTC) 1707 VESTIGE study.
Lordick F, Mauer ME, Stocker G, Cella CA, Ben-Aharon I, Piessen G, Wyrwicz L, Al-Haidari G, Fleitas-Kanonnikoff T, Boige V, Lordick Obermannová R, Martens UM, Gomez-Martin C, Thuss-Patience P, Arrazubi V, Avallone A, Shiu KK, Artru P, Brenner B, Buges Sanchez C, Chau I, Lorenzen S, Daum S, Sinn M, Merelli B, van Grieken NCT, Nilsson M, Collienne M, Giraut A, Smyth E. Lordick F, et al. Ann Oncol. 2024 Nov 13:S0923-7534(24)04906-8. doi: 10.1016/j.annonc.2024.10.829. Online ahead of print. Ann Oncol. 2024. PMID: 39542422 Free article.
VESTIGE: Adjuvant Immunotherapy in Patients With Resected Esophageal, Gastroesophageal Junction and Gastric Cancer Following Preoperative Chemotherapy With High Risk for Recurrence (N+ and/or R1): An Open Label Randomized Controlled Phase-2-Study.
Smyth E, Knödler M, Giraut A, Mauer M, Nilsson M, Van Grieken N, Wagner AD, Moehler M, Lordick F. Smyth E, et al. Among authors: lordick f. Front Oncol. 2020 Jan 30;9:1320. doi: 10.3389/fonc.2019.01320. eCollection 2019. Front Oncol. 2020. PMID: 32083013 Free PMC article.
Management of Metastatic Gastric Cancer.
Obermannová R, Lordick F. Obermannová R, et al. Among authors: lordick f. Hematol Oncol Clin North Am. 2017 Jun;31(3):469-483. doi: 10.1016/j.hoc.2017.01.006. Epub 2017 Mar 22. Hematol Oncol Clin North Am. 2017. PMID: 28501088 Review.
Gastric cancer.
Smyth EC, Nilsson M, Grabsch HI, van Grieken NC, Lordick F. Smyth EC, et al. Among authors: lordick f. Lancet. 2020 Aug 29;396(10251):635-648. doi: 10.1016/S0140-6736(20)31288-5. Lancet. 2020. PMID: 32861308 Review.
Targeting HER2 for localised oesophageal cancer.
Lordick F, Obermannová R, Smyth EC. Lordick F, et al. Lancet Oncol. 2022 Feb;23(2):188-190. doi: 10.1016/S1470-2045(22)00004-3. Epub 2022 Jan 14. Lancet Oncol. 2022. PMID: 35038428 No abstract available.
Two steps forward and one step back.
Lordick F, Smyth EC. Lordick F, et al. Nat Rev Clin Oncol. 2019 Feb;16(2):69-70. doi: 10.1038/s41571-018-0154-4. Nat Rev Clin Oncol. 2019. PMID: 30575811 No abstract available.
471 results